Regulatory Approval Challenges: Obtaining and maintaining necessary regulatory approvals (e.g., FDA, CE Mark) is a complex, time-consuming, and expensive process. Delays or failures in securing these approvals could prevent or significantly delay product commercialization.

Intense Competition and Market Share Erosion: The bionics and medical exoskeleton market is highly competitive, with numerous established and emerging players. Failure to innovate, differentiate products, or effectively market them could lead to a loss of market share and reduced sales.

Intellectual Property Protection Concerns: Ekso Bionics relies heavily on its patents and proprietary technology. The inability to adequately protect its intellectual property from infringement, or the expiration of key patents, could weaken its competitive position and allow competitors to replicate its technologies.